[PHARMA] QoQ Cumulative Quarter Result on 30-Sep-2013 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
19-Nov-2013
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2013
Quarter
30-Sep-2013 [#3]
Profit Trend
QoQ- 12.24%
YoY- -50.63%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Cumulative Result
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
Revenue 993,744 468,672 1,946,639 1,378,779 937,972 500,339 1,812,346 -33.08%
PBT 62,781 38,159 92,997 59,990 46,529 36,924 103,313 -28.32%
Tax -20,178 -11,513 -36,236 -24,496 -15,205 -11,771 -40,108 -36.82%
NP 42,603 26,646 56,761 35,494 31,324 25,153 63,205 -23.17%
-
NP to SH 42,192 26,217 55,200 34,387 30,636 24,771 61,710 -22.44%
-
Tax Rate 32.14% 30.17% 38.96% 40.83% 32.68% 31.88% 38.82% -
Total Cost 951,141 442,026 1,889,878 1,343,285 906,648 475,186 1,749,141 -33.45%
-
Net Worth 502,162 515,022 486,754 473,857 481,681 484,829 471,886 4.24%
Dividend
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
Div 20,707 10,352 41,477 25,427 17,661 8,825 41,187 -36.85%
Div Payout % 49.08% 39.49% 75.14% 73.95% 57.65% 35.63% 66.74% -
Equity
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
Net Worth 502,162 515,022 486,754 473,857 481,681 484,829 471,886 4.24%
NOSH 258,846 258,805 258,911 258,938 258,968 117,676 117,677 69.37%
Ratio Analysis
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
NP Margin 4.29% 5.69% 2.92% 2.57% 3.34% 5.03% 3.49% -
ROE 8.40% 5.09% 11.34% 7.26% 6.36% 5.11% 13.08% -
Per Share
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
RPS 383.91 181.09 751.85 532.47 362.20 425.18 1,540.10 -60.49%
EPS 16.30 10.13 21.32 13.28 11.83 21.05 52.44 -54.21%
DPS 8.00 4.00 16.02 9.82 6.82 7.50 35.00 -62.71%
NAPS 1.94 1.99 1.88 1.83 1.86 4.12 4.01 -38.45%
Adjusted Per Share Value based on latest NOSH - 258,689
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
RPS 68.95 32.52 135.07 95.67 65.08 34.72 125.75 -33.08%
EPS 2.93 1.82 3.83 2.39 2.13 1.72 4.28 -22.37%
DPS 1.44 0.72 2.88 1.76 1.23 0.61 2.86 -36.79%
NAPS 0.3484 0.3573 0.3377 0.3288 0.3342 0.3364 0.3274 4.24%
Price Multiplier on Financial Quarter End Date
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
Date 30/06/14 31/03/14 31/12/13 30/09/13 28/06/13 29/03/13 31/12/12 -
Price 4.61 4.46 4.45 4.82 4.49 8.26 8.10 -
P/RPS 1.20 2.46 0.59 0.91 1.24 1.94 0.53 72.68%
P/EPS 28.28 44.03 20.87 36.30 37.95 39.24 15.45 49.80%
EY 3.54 2.27 4.79 2.76 2.63 2.55 6.47 -33.17%
DY 1.74 0.90 3.60 2.04 1.52 0.91 4.32 -45.55%
P/NAPS 2.38 2.24 2.37 2.63 2.41 2.00 2.02 11.58%
Price Multiplier on Announcement Date
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
Date 21/08/14 14/05/14 24/02/14 19/11/13 16/08/13 15/05/13 18/02/13 -
Price 4.62 4.70 4.29 4.72 4.66 9.26 7.80 -
P/RPS 1.20 2.60 0.57 0.89 1.29 2.18 0.51 77.18%
P/EPS 28.34 46.40 20.12 35.54 39.39 43.99 14.87 53.90%
EY 3.53 2.16 4.97 2.81 2.54 2.27 6.72 -34.97%
DY 1.73 0.85 3.73 2.08 1.46 0.81 4.49 -47.14%
P/NAPS 2.38 2.36 2.28 2.58 2.51 2.25 1.95 14.24%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment